OPR - Delayed Quote • USD DSGN Jul 2024 2.500 put (DSGN240719P00002500) Follow 0.2000 0.0000 (0.00%) At close: April 16 at 9:30 AM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for DSGN240719P00002500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: DSGN Independent Director of Design Therapeutics Picks Up 88% More Stock Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript Q4 2023 Design Therapeutics Inc Earnings Call Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update Design Therapeutics, Inc. (DSGN) Upgraded to Buy: Here's What You Should Know Positive Signs As Multiple Insiders Buy Design Therapeutics Stock Design Therapeutics Inc (DSGN) Reports Q3 2023 Financials, Plans Strategic Update Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024 Why Shares of Design Therapeutics Are Plummeting on Tuesday Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls
